Literature DB >> 34738205

Early corneal and optic nerve changes in a paediatric population affected by obstructive sleep apnea syndrome.

Erika Bonacci1, Adriano Fasolo1, Marco Zaffanello2, Tommaso Merz1, Giacomo Brocoli1,3, Angelo Pietrobelli2, Maria Clemente2, Alessandra De Gregorio4, Rosa Longo1, Francesca Bosello5, Giorgio Marchini1, Emilio Pedrotti1.   

Abstract

PURPOSE: The relation between OSAS and eye diseases is well known in adults, while very few and contradictory data can be found regarding paediatric ages. The aim of this study is to explore the early corneal, macular and optic nerve changes in paediatric patients with OSAS.
METHODS: Prospective study that enrolled children aged ≥ 4 years referred to the Paediatric Pneumology Clinic in Verona for suspected obstructive sleep apnoea syndrome (OSAS) and investigated with the overnight respiratory polygraphy. Patients with apnoea-hypopnea index (AHI) > 1 were classified as OSAS, while those with AHI < 1 were classified non-OSAS. All patients underwent comprehensive eye examination including slit lamp, refraction, intraocular pression (Goldman applanation tonometry), corneal tomography (corneal astigmatism, corneal keratometry at the apex, surface asymmetry index, central corneal thickness and thinnest corneal thickness) and optical coherence tomography (central macular thickness, macular volume and retinal nerve fibre layer).
RESULTS: Seventy-two children were enrolled in the study. The overall prevalence of OSAS was 48.6%. Statistically significant differences were found between OSAS and non-OSAS group for corneal asymmetry (0.9 ± 0.5 and 0.6 ± 0.3, respectively; p = 0.02), thinnest corneal thickness (551.8 ± 33.9 and 563.7 ± 32.5; p = 0.04), average retinal nerve fibre layer (102.8 ± 10.5 µm and 98.1 ± 12.3 µm; p = 0.012) and in nasal quadrant (76.2 ± 15.4 µm and 66.5 ± 12.6 µm; p = 0.0002).
CONCLUSIONS: A comprehensive eye examination with corneal and optic nerve imaging showed early corneal and optic nerve changes in children newly diagnosed with OSAS. These could be prelude of the known ocular manifestations associated with OSAS in adult patients.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Keratoconus; OSAS; Obstructive sleep apnoea syndrome; Paediatric ophthalmology; RNFL; Sleep respiratory disorders

Mesh:

Year:  2021        PMID: 34738205     DOI: 10.1007/s10792-021-02115-2

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  4 in total

1.  Keratoconus: an analysis of corneal asymmetry.

Authors:  D M Burns; F M Johnston; D G Frazer; C Patterson; A J Jackson
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

2.  Associations between Optic Disc Measures and Obstructive Sleep Apnea in Young Adults.

Authors:  Samantha S Y Lee; Nigel McArdle; Paul G Sanfilippo; Seyhan Yazar; Peter R Eastwood; Alex W Hewitt; Qiang Li; David A Mackey
Journal:  Ophthalmology       Date:  2019-05-17       Impact factor: 12.079

3.  Retinal nerve fiber layer thickness changes in obstructive sleep apnea syndrome: a systematic review and Meta-analysis.

Authors:  Jia-Song Wang; Hua-Tao Xie; Ye Jia; Ming-Chang Zhang
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

4.  Optic disc and retinal nerve fiber layer parameters as indicators of neurodegenerative brain changes in patients with obstructive sleep apnea syndrome.

Authors:  Nergiz Huseyinoglu; Metin Ekinci; Serkan Ozben; Cagatay Buyukuysal; Murat Yildirim Kale; Hilal Safak Sanivar
Journal:  Sleep Breath       Date:  2013-05-01       Impact factor: 2.816

  4 in total
  2 in total

Review 1.  Preservation of corneal stromal lenticule: review.

Authors:  Martina Nemcokova; Jakub Dite; Yun Min Klimesova; Magdalena Netukova; Pavel Studeny
Journal:  Cell Tissue Bank       Date:  2022-02-06       Impact factor: 1.522

2.  Pediatric Sleep-Disordered Breathing and Long-Term Complications: Clinical and Health Implications.

Authors:  Marco Zaffanello; Massimo Franchini; Giorgio Piacentini
Journal:  J Clin Med       Date:  2022-09-01       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.